Early research (Phase 1)UnknownNCT06478381What this trial is testingL218CAR19 in Patients With Relapsed/Refractory B-cell LymphomaWho this might be right forRelapsed/Refractory B-cell Lymphomas Henan Cancer Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00873457What this trial is testingPerifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Daphne Friedman 16
Testing effectiveness (Phase 2)Study completedNCT02000427What this trial is testingBlinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic LeukemiaWho this might be right forRelapsed/Refractory Philadelphia Positive B-precursor ALL Amgen 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361What this trial is testingBAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple MyelomaWho this might be right forNon-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more Luminary Therapeutics 90
Early research (Phase 1)Study completedNCT03472573What this trial is testingPalbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Early research (Phase 1)Active Not RecruitingNCT03283137What this trial is testingCombination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHLWho this might be right forCLLB-cell Non Hodgkin Lymphoma University of Chicago 20
Not applicableUnknownNCT06142175What this trial is testingRelmacabtagene Autoleucel in Patients With LBCLWho this might be right forLarge B-cell Lymphoma Shanghai Ming Ju Biotechnology Co., Ltd. 200
Very early researchUnknownNCT03692767What this trial is testingStudy of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell LymphomaWho this might be right forRefractory B-Cell Lymphoma Allife Medical Science and Technology Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT03196830What this trial is testingCAR-T for R/R B-NHLWho this might be right forRelapsed Non Hodgkin LymphomaRefractory Non-Hodgkin LymphomaCAR - T CD19/CD20/CD22/CD30 The First Affiliated Hospital of Soochow University 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572What this trial is testingGlofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell TherapyWho this might be right forDiffuse Large B Cell Lymphoma Samsung Medical Center 30
Large-scale testing (Phase 3)WithdrawnNCT00551239What this trial is testingFludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWho this might be right forLeukemiaLymphoma CTI BioPharma
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)Looking for participantsNCT06313957What this trial is testingLUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma Peking University Cancer Hospital & Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT05648019What this trial is testingCD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility ProtocolWho this might be right forLymphoblastic LeukemiaLymphoblastic Leukemia in ChildrenLymphoblastic Leukemia, Acute Adult+3 more KK Women's and Children's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03575325What this trial is testingVyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic LeukemiaWho this might be right forLymphoid LeukemiaAcute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia+1 more H. Lee Moffitt Cancer Center and Research Institute 11
Testing effectiveness (Phase 2)Study completedNCT02332980What this trial is testingPembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more Mayo Clinic 65
Testing effectiveness (Phase 2)Study completedNCT04298879What this trial is testingIBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone LymphomaWho this might be right forIndolent Non-hodgkin Lymphoma Innovent Biologics (Suzhou) Co. Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT01497496What this trial is testingOfatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma H. Lee Moffitt Cancer Center and Research Institute 29
Early research (Phase 1)Active Not RecruitingNCT01959698What this trial is testingCarfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell LymphomaWho this might be right forCD20 PositiveRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+4 more Roswell Park Cancer Institute 29
Large-scale testing (Phase 3)UnknownNCT00020865What this trial is testingLevofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+3 more Jonsson Comprehensive Cancer Center